Cerebral palsy (CP) is a neurodevelopmental disorder that affects motor function and is often associated with spasticity, which can result in pain and reduced quality of life. OnabotulinumtoxinA, commonly known as Botox, has been used as a treatment for spasticity in CP. This article reports on a phase 3, multinational, randomized, double-blind, placebo-controlled trial that evaluated the safety and efficacy of onabotulinumtoxinA for lower limb … Continue reading Is onabotulinumtoxinA effective in reducing lower limb spasticity in children with cerebral palsy?